Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an ag...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the company, through a subsidiary...
Morgan Stanley analyst Terence Flynn maintains Merck & Co (NYSE:MRK) with a Equal-Weight and raises the price target fro...
The Merck Foundation announced today the launch of the Collaborative for Equity in Cardiac Care, a $22 million, five-year initi...
-Reuters
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the...
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...
Merck shares dipped after strong earnings and higher profit guidance, as the company narrowed its 2025 sales forecast amid mixe...
- Reuters Citing Conf Call
